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In recent years, ecstasy trafficking has grown in complexity and tablets has been commonly 
sold containing different contents of 3,4-methylenedioxymethamphetamine (MDMA) or even other 
psychoactive substances. In contrast, identification and quantification of drugs of abuse is still a 
challenge, once the access to drug standards is very restricted in Brazil. In this work, ecstasy tablets 
seized by the Brazilian Federal Police have their chemical composition identified and quantified 
by gas chromatography and quantitative 1H nuclear magnetic resonance based on an internal 
standard approach (IS-1H-qNMR). Both methods were validated and showed suitable results for 
the figures of merit. IS-1H-qNMR shows excellent results of accuracy (relative error < 5%) and 
precision (relative standard deviation (RSD) < 2%). Comparatively, IS-1H-qNMR is more efficient 
and versatile than gas chromatography to accomplish in a single analysis the identification and 
quantification of target analytes. Since the method does not require a specific reference material, 
it is cost effective and provides agility to routine forensic analysis.
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Introduction
The term “ecstasy” is typically used to describe 
tablets containing 3,4-methylenedioxy methamphetamine 
(MDMA), or its hydrochloride salt (MDMA.HCl), which 
vary in shapes, dimensions, colors, and logos. In recent 
years, the ecstasy trafficking has grown in complexity 
and diversification. The addition of other amphetamine 
type substances (ATS) became a common practice and 
substances such as 3,4-methylenedioxyethylamphetamine 
(MDEA), 3,4-methylenedioxy amphetamine (MDA), and 
other chemicals classes, such as piperazines or cathinones, 
are occasionally detected. Moreover, tablets are commonly 
sold containing little or no MDMA, or with an extremely 
high content of MDMA.1
A study on the composition of ecstasy tablets in Brazil, 
carried out on samples from 150 different seizures (from 
August 2011 to July 2012) showed a strong tendency in 
tablet adulteration. An unexpected result was the presence 
of methamphetamine in 22% of the tablets analyzed.2 
Despite seizures of ATS are generally less frequent in 
Latin America than in other global markets, considerable 
amounts were seized in Brazil in 2014 (238 kg) and 2015 
(153 kg).1
This scenario is associated with the unregulated and 
illegal activity,3-6 and in-depth characterization of ecstasy 
tablets can provide important information for intelligence 
services as well as public health agencies. The chemical 
profiling analysis allows, for example, the comparison of 
samples similarity, indication of geographic origin, definition 
of distribution networks, evaluation of synthetic routes, and 
other valuable information to law enforcement agencies.
The most widely used technique for MDMA 
quantification in ecstasy tablets is the gas chromatography 
(GC), which can be coupled with various detectors, such as 
mass spectrometry (MS), flame ionization detector (FID) 
or nitrogen phosphorus detector (NPD). On the other hand, 
the determination of ecstasy purity can also be conducted 
by methods that do not involve a separation step, such as 
near infrared spectroscopy (NIR) and quantitative nuclear 
magnetic resonance of hydrogen (1H-qNMR).7-9
Actually, the 1H-qNMR spectroscopy could be more 
explored as an important tool in forensic science, since 
it provides a direct proportionality between a signal area 
and the number of nuclei responsible for that signal. As a 
result, the technique does not require a reference standard 
A Validated NMR Approach for MDMA Quantification in Ecstasy Tablets J. Braz. Chem. Soc.2
containing the target analyte, which is, in the case of illicit 
drugs in developing countries, not always readily available, 
extremely expensive and difficult to obtain. Besides that, 
NMR can simultaneously perform the identification and 
quantification of other substances also present in ecstasy 
tablets, like adulterants, that is still a challenge in forensic 
drug analysis.7,10,11
Herein, we develop and validate an 1H-qNMR 
analytical method, based on an internal standard approach 
(IS-1H-qNMR), for quantification of MDMA in ecstasy 
tablets. The IS-1H-qNMR method is simple, accurate and 
fast, and does not demand any previous separation step. Once 
the GC-FID is a reference method routinely used in forensic 
laboratories, it was used to evaluate the NMR-based method. 
Finally, the validated method was applied to a set of ecstasy 
tablets seized by Brazilian Federal Police.
Experimental
Chemical and reagents
All chemicals were of analytical grade or better 
and used without additional purification procedures. 
Dipentylphthalate (97.0%) was obtained from Acros 
Organics (Brazil). Maleic acid (MA, 99.99%) and dimethyl 
sulfone (DMS, 99.73%) certified standards, diethylamine, 
chloroform and deuterium oxide (D2O) were obtained from 
Sigma-Aldrich (Brazil). The MDMA.HCl certified standard 
(99.6%) was obtained from National Measurement Institute 
(Australia). A total of 38 different ecstasy tablets were 
analyzed by GC-FID and 1H-qNMR. The seized tablets 
were obtained from the National Institute of Criminalistics 
of the Brazilian Federal Police. Before analysis, tablets 
were manually crushed in mortar into fine powders.
GC-FID experiments
Quantitative analyses were a routine practice in the 
Brazilian Federal Police laboratory to study the cocaine 
profile12 and a similar GC-FID MDMA.HCl quantification 
protocol was firstly validated to be used as a reference 
method to IS-1H-qNMR analysis.
Approximately 10 ± 0.01 mg of sample or MDMA.HCl 
reference material were weighted in an XP205 Mettler 
Toledo scale, mixed with 10.0 mL of dispensed internal 
standard solution (dipentylphthalate at 0.490 mg mL-1 in 
CHCl3 / 0.2% diethylamine) and carefully stirred until 
dissolution. Freshly prepared solutions were transferred to 
2 mL glass vials and sealed for further gas chromatography 
injection. Homogenized seized samples were used to 
evaluate some of the figures of merit in validation stages 
(e.g. precision and stability), due to the low availability of 
MDMA.HCl standards.11
The GC was performed with an Agilent Technologies® 
6890N gas chromatograph equipped with flame ionization 
detector and 25 m × 0.2 mm × 0.33 µm RXI-1MS or 
DB-1MS Agilent Technologies® columns. Injector was 
operated in the split mode (50:1) at 280 °C and injection 
volume of 1 µL. Helium was used as the carrier gas at 
constant flow rate of 1.0 mL min-1. The oven temperature 
was programmed as follow: 150 °C (2 min), followed 
by a heating ramp of 30 °C min-1 up to 315 °C (hold for 
4.5 min). The total analysis time was 12 min. The FID 
was maintained at 320 °C, with hydrogen flow rate of 
35.0 mL min-1, air flow rate of 350.0 mL min-1 and nitrogen 
flow rate of 35.0 mL min-1.
For GC-FID validation, the following figures of 
merit were assessed: linearity, selectivity, precision, 
accuracy, robustness (Youden’s test), stability, limits of 
detection (LOD) and quantification (LOQ) and uncertainty 
estimation. The Grubbs test was applied for outliers 
identification.13,14 GC-FID was used to identify other active 
ingredients, like adulterants, on seized ecstasy tablets.
NMR spectroscopy experiments
For IS-1H-qNMR, MA and DMS certified standards 
were used to evaluate the figures of merit, in which MA 
was assigned as internal standard and DMS as the analyte 
to be quantified. To assure that the IS-1H-qNMR method 
could be applied to MDMA quantification, MDMA.HCl 
certified reference material was also used to verify some 
figures of merit.
Approximately 20 ± 0.01 mg of sample and 11 ± 0.01 mg 
of MA were weighted in the same Eppendorf tube. The 
powders were mixed in 1.2 mL of D2O, stirred 1 min in a 
vortex and centrifuged 5 min at 2,000 rpm to separate any 
insoluble material. About 1 mL of the clear upper solution 
was carefully transferred with a pipette to the NMR tubes.
The IS-1H-qNMR measurements were carried out 
on a Bruker Avance III HD 600 instrument (operating at 
600.13 MHz) equipped with 5 mm broadband observe 
probe (BBFO). Lock and shimming adjustments were 
done automatically for all samples. Tuning and matching 
adjustment were done manually. The 90° pulse value was 
automatically calculated using the pulsecal command. To 
avoid sidebands and minimize eventual signal overlapping 
all 1H spectra were acquired without sample spinning 
and with 13C decoupling during acquisition (zgig30 pulse 
sequence). The following parameters were optimized for 
IS-1H-qNMR: 30° pulse angle, pre-acquisition delay of 
10 µs, 64 k data points (corresponding to an acquisition 
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time of 2.7 s at a sweep width of 20 ppm), irradiation 
frequency offset (o1p) of 6.17 ppm, relaxation delay of 
25 s and a total of 16 scans and 4 dummy scans. To ensure 
complete relaxation, all acquisitions were made with a 
relaxation delay of at least 10 times the largest T1 (spin-
lattice relaxation time) value. For determination of the 
relaxation delay value, T1 measures of all analytes were 
previously performed by inversion-recovery experiments. 
T1 constants ranged from typical 2 s values for MDMA to 
approximately 6 s for DMS and MA molecules. The sample 
temperature in the probe was maintained at 28 °C.
Fourier transformation (FT) was applied after zero filling 
the data to 64 k time domain points. The acquired NMR 
spectra were manually phase-corrected and baseline was 
automatically set with fifth order polynomial function. The 
spectra were referenced by TSP-d4 (sodium-2,2,3,3-d4-3- 
trimethylsilylpropionate) signal (0 ppm) and integrations 
were manually made using Bruker Topspin 3.2 software. 
For quantification, a well-known equation was applied, 
which includes the molar weight, integral area, number of 
protons of the reference compound and analyte, as well as 
purity and gravimetric mass of the reference.6,9
For validation, the following figures of merit were 
evaluated: linearity, selectivity, precision, accuracy, robustness 
(Youden’s test), stability, limits of detection and quantification, 
and uncertainty estimation. Grubbs test was applied for outliers 
identification13,14 and results of samples analyzed by both 
GC-FID and IS-1H-qNMR were evaluated by paired t-test.
Infrared spectroscopy (FTIR/ATR (attenuated total 
reflectance), Nicolet iS10 model, equipped with a 
SMART iTR accessory) was used to identify the main 
ecstasy tablets cutting agents. The active ingredients were 
selectively extracted with methanol and the insoluble 
material was dried and analyzed by FTIR/ATR.
Results and Discussion
Validation of MDMA quantitative analysis by GC-FID
An analytical curve was plotted for MDMA.HCl 
concentrations ranging from 0.02 to 0.90 mg mL-1. As 
shown in Table 1, GC-FID method demonstrates excellent 
results for all assessed analytical parameters. The analytical 
curve presents low residues (< 0.01) and a relative standard 
deviation (RSD) smaller than 2.0% at all measured points. 
The method was considered linear over the entire studied 
concentration range. The method is also precise in terms 
of repeatability (same analyst, same day, six replicates at 
three levels of MDMA concentration) and intermediate 
precision (same analyst and equipment in different days; 
same equipment in the same day by different analysts; same 
analyst in the same day and in different equipment). The 
GC-FID method was also accurate in high (80%), medium 
(40%) and low (20%) levels of MDMA.HCl purity with 
certified standard mixtures with cellulose and robust for all 
variables evaluated (flow rate, injector temperature, oven 
temperature, split ratio, injection volume). The limits of 
detection and quantification and the combined standard 
uncertainty are adequate for the proposed application.
The potential interference of some traditional ATS 
(MDEA, MDA and amphetamine) and pharmaceutical 
adulterants (paracetamol, caffeine, mephedrone, benzocaine, 
phenacetin, lidocaine, aminopyrine, levamisole and 
procaine) present in ecstasy tablets was also evaluated. The 
chromatograms analyses (Figure S1 in the Supplementary 
Information (SI) section) show that the GC-FID method 
is selective for MDMA, since no interferents are present 
in its individual elution zone.
The stability was also assessed for solutions stored 
2 months in freezer (–15 °C) and 13 days at room 
temperature. Relative errors are smaller than ± 5.0% during 
those periods.
Once validated, the GC-FID method was applied to 
the United Nations Office on Drugs and Crime (UNODC) 
proficiency test.15 The quantitative result of an MDMA-
containing sample analyzed by our method was amongst 
the 10 most accurate results of 98 attendees’ laboratories 
from different countries, confirming the efficiency of 
our method. Currently, this method is part of the quality 
assurance system of Brazilian Federal Police laboratory 
and has been used routinely.
Validation of IS-1H-qNMR method
Initially, MA and DMS solutions were used as reference 
to evaluate the figures of merit of a general method for 
Table 1. GC-FID validation results
Figure of merit Result
Analytical curve y = 0.68435x + 0.00561
Coefficient of determination (R2) 0.99987
Equipment repeatability RSD < 0.2%
Method repeatability RSD < 2.2%
Intermediate precision RSD < 3.0%
Accuracy relative error < 3.6%
Robustness relative error < 0.25%; 
RSD < 0.5%
Limit of detection (LOD) / (mg mL-1) 0.0034
Limit of quantification (LOQ) / (mg mL-1) 0.0112
Expanded uncertainty / % 6.28
RSD: relative standard deviation.
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quantitative analysis by 1H-qNMR using internal standard. 
Once satisfactory results were achieved, the particularities 
for quantification of MDMA.HCl by IS-1H-qNMR were 
addressed.
In order to assess the linearity of IS-1H-qNMR method, 
a curve ranging from 5 to 95% of MA/(DMS + MA) 
molar ratio was constructed. For this purpose, the integral 
values of MA (6.4 ppm, singlet) were used to quantify 
DMS (3.1 ppm, singlet). The linear regression and the 
coefficient of determination (R2 = 1.00000) shows a clear 
linear relationship between the molar ratio of expected 
values (gravimetric) and the experimental values (NMR 
integral) on the analyzed range. The residues obtained are 
small (less than 0.3%) and homoscedastic, with suitable 
distribution along the curve, and thus confirm the linearity 
of the method.
The IS-1H-qNMR method shows good precision 
results in all three tests (equipment repeatability, method 
repeatability and intermediate precision). The equipment 
repeatability, analyzed at 61% MA/(DMS + MA) molar 
ratio, showed an RSD of 0.08%. The RSD values obtained 
for method repeatability and intermediate precision are 
lower than 2% for the three levels of molar ratio evaluated 
(low (10%), medium (60%) and high (80%)). Good results 
are also observed in the accuracy assessment, once the 
relative errors obtained for the three levels of molar ratio 
evaluated are lower than 4%.
Number of scans, receiver gain, sample temperature, 
quality of NMR tubes (Selection or Economy Wilmad®), 
processing software (ACD/Spectrus Processor or Bruker 
Topspin 3.2), integration criterion (automatic or manual 
integration) and line broadening function were the 
parameters selected to assess the method robustness. After 
analysis of 16 samples, the effect of each parameter was 
calculated using the Youden’s test. Results presented in 
Figure 1 show that all analyzed parameters have effects’ 
values within the confidence interval (CI). Therefore, they 
do not affect the results of quantification by IS-1H-qNMR 
and the method is considered robust in regard to acquisition 
and processing of the parameters investigated.
The LOD and LOQ were calculated by curve 
extrapolation and are 0.12 and 0.41% of molar ratio 
of DMS, respectively, which means that the minimum 
quantified amount of DMS is 0.03 mg, considering a 
weighing of 10.00 mg of MA.
Solutions containing MA and DMS are stable for at least 
20 days at room temperature, since subsequent analyses 
show relative errors below 0.5% for low, medium and high 
levels of molar ratio evaluated.
The combined standard uncertainty calculation takes 
into account contributions from all important uncertainty 
sources, like gravimetric mass and molecular weight of 
MA and DMS, purity of MA, integral ratio of MA and 
DMS and recovery. The combined standard uncertainty was 
0.27% and the calculated contribution of each component 
shows that recovery is the main factor for whole method 
uncertainty (85.66%). This result is expected once recovery 
is actually a combination of various factors, such as sample 
preparation and purity of internal standard and analyte. 
The expanded uncertainty is obtained by each sample’s 
purity, in percentage, multiplied by the combined standard 
uncertainty value (0.54%) to 95% confidence coverage 
factor (k = 2). Afterward, the final results to determine DMS 
purity and expanded uncertainty, obtained by the validated 
1H-qNMR method, are 99.90 ± 0.54%. The uncertainty 
estimation of the 1H-qNMR method presents acceptable 
value and corroborates the power of this technique when 
combined with careful sample preparation.
Quantitative analysis of MDMA.HCl by 1H-qNMR
Once the validation of a general IS-1H-qNMR approach 
has been concluded, the same procedure was applied to 
MDMA.HCl quantification. Complete assignment of 
MDMA.HCl signals in 1H NMR spectrum is presented 
in Figure 2 and summarized in Table S1 (SI section). The 
signal of the methylenedioxy group (5.97 ppm; E signal 
in Figure 2) was chosen to quantify MDMA.HCl, since 
it is a singlet in a relatively quiet region, reducing the 
possibility of interference, and it can be used to discriminate 
MDMA.HCl from other ATS, such as methamphetamine 
and amphetamine.
Selectivity of IS-1H-qNMR for MDMA is initially 
demonstrated by verifying that the signals used for 
quantification, MA (6.42 ppm) and MDMA.HCl (5.97 ppm), 
and the signals of the main adulterants or cutting agents 
Figure 1. Effect of different parameters evaluated to 1H-qNMR method 
robustness.
Almeida et al. 5Vol. 00, No. 00, 2018
found in real samples (amphetamine, aminopyrine, caffeine, 
sucrose and procaine) do not present overlapping. This is 
shown in Figure S2 (SI section). In addition, MDMA.HCl 
quantification performed in the presence of a mixture of 
the main adulterants showed a relative error below 4%, a 
value that is considered acceptable for the method.
The precision of the method was also determined for 
MDMA.HCl (3 replicates) and showed an RSD value 
of 1.82%, very close to the one found in the MA/DMS 
solutions, and considered adequate for the proposed 
application.
The accuracy experiments previously performed with 
DMS cannot be directly applied for solutions of different 
analytes or solvents. A good recovery depends on the 
extraction step, which is particularly critical in samples 
with lower purity, and recovery experiments must be 
designed considering matrix complexity. In our method, 
the accuracy was evaluated by the analysis of mixtures of 
cellulose and 40% of MDMA.HCl standards (3 replicates), 
and the relative error values obtained for MDMA are 
below 4.5%. These values are similar to those found in the 
MA/DMS solutions, showing that the method is also 
accurate to MDMA.HCl analyte.
The LOQ and LOD were determined by means of 
signal-to-noise (S/N) ratio of 30 and 10, respectively. The 
LOQ and LOD are 0.67 and 0.22%, respectively, far below 
the lowest MDMA.HCl concentration determined in real 
samples.
The stability of MDMA.HCl and MA solutions in 
D2O was also assessed using the solutions prepared for 
recovery experiment. Solutions were analyzed, stored at 
room temperature in NMR tubes and analyzed again in 
72 h. Relative errors < 0.2% showed that the solutions can 
be considered stable for the period studied.
IS-1H-qNMR method uncertainty was also estimated 
for MDMA.HCl determination. The contribution of each 
component (gravimetric mass, molecular weight, purity 
of internal standard, integral ratio of analyte and internal 
standard and recovery) was calculated considering the 
square of the standard uncertainty. The result shows that 
recovery is again the main factor for NMR uncertainty 
(98.53%). The expanded uncertainty was obtained by 
each sample’s purity, in percentage, multiplied by the 
combined standard uncertainty value (1.06%) and the 95% 
confidence coverage factor (k = 2). It is interesting to note 
that the expanded uncertainty of MDMA quantification 
Figure 2. Molecular structure and 1H NMR spectrum (600.13 MHz) of MDMA.HCl in D2O with MA (internal standard). The letters identify hydrogens 
of MDMA molecular structure.
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by IS-1H-qNMR method (2.12%) is lower than the value 
estimated by the GC-FID reference method (6.28%).
Quantitative analysis of MDMA in seized ecstasy tablets
Finally, real samples of seized ecstasy tablets were 
analyzed and MDMA was quantified both by GC-FID 
and IS-1H-qNMR validated methods. Seizures were 
separated in 38 batches according to geographical origin, 
apprehension date and physical characteristics (e.g. shape, 
color and logo). The seized tablets present seventeen 
different logos, weights between 158 and 430 mg and 
five different excipients were identified by FTIR analysis 
(cellulose, sucrose, starch, talc, and fatty esters of long 
chain). In fact, cellulose was identified in more than 60% 
of the batches. Besides MDMA, at least one adulterant 
(among aminopyrine, caffeine, procaine or amphetamine) 
was identified in 15% of analyzed samples. The MDMA.
HCl purity ranges from 10 to 77%, representing mass of 
39 to 152 mg per tablet.
A comparison of GC-FID and IS-1H-qNMR results 
is shown in Figure 3. The curve presents an adequate 
correlation with slope of 0.936, interception on the y-axis 
at 0.02 and R2 value of 0.9909. As desired, the residues 
calculated for IS-1H-qNMR method and those predicted 
by the curve are below 5% for all samples. Moreover, the 
residues values are randomized and show neither bias nor 
curvatures.
When applying a paired t-test, in which the null 
hypothesis (H0) is the equality of the two methods results 
(H0: mean of the paired differences (µ) = 0), the value of 
observed t (tobs = 1.93) is included in the critical region 
defined by tabulated values (–2.026 < tobs < 2.026) and 
the p-value is greater than 0.05 (p = 0.061). Then, H0 is 
acceptable at the 5% level of significance. In addition, the 
µ value for H0 is within the limits obtained for the 95% 
confidence interval (–0.0003 < µ < 0.01243). Therefore, 
the results obtained by the two methods can be considered 
statistically equal.
Conclusions
The IS-1H-qNMR method applied to MDMA 
quantification in ecstasy tablets developed in this work was 
validated with very good results. The sample preparation 
is simple, fast and convenient. Since it is not necessary to 
prepare specific analytical curves, this method demands 
less work and time. Besides that, the possibility of NMR 
to identify virtually any active substance of an illegal drug 
and to quantify it without using the standard of the target 
analyte are the major advantages of this technique when 
compared to the commonly used chromatographic methods. 
In fact, once the method does not demand for specific 
certified reference material, it can be applied to reduce 
costs and to provide agility for forensic analysis, which 
always handles urgency in results and faces unpredictable 
samples composition.
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